Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Actavis Inc. has made an agreement with the FDA not to issue any drugs from its Totowa facilities in Morristown, N.J., where Digitek is produced.

According to the Philadelphia Inquirer, the agreement says Actavis cannot resume its practices until it conforms to “the agency’s good manufacturing practice.” Actavis must improve its labs, facilities, and equipment.

Actavis has faced numerous lawsuits over the recalled drug Digitek. One such lawsuit includes the death of a patient and claims that Digitek is an unsafe and flawed drug.

Actavis would not comment if the FDA agreement had influenced the Digitek lawsuits or not.

This entry was posted on Monday, January 5th, 2009 at 9:58 am and is filed under Digitek Legal, Digitek recall, News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.